PT1023077E - Composicao oftalmica - Google Patents

Composicao oftalmica

Info

Publication number
PT1023077E
PT1023077E PT98908415T PT98908415T PT1023077E PT 1023077 E PT1023077 E PT 1023077E PT 98908415 T PT98908415 T PT 98908415T PT 98908415 T PT98908415 T PT 98908415T PT 1023077 E PT1023077 E PT 1023077E
Authority
PT
Portugal
Prior art keywords
composition
sodium hyaluronate
ofthalmic
range
conducting
Prior art date
Application number
PT98908415T
Other languages
English (en)
Inventor
Fergeus Susanna
Lundberg Kerstin
Wik Ove
Original Assignee
Pfizer Health Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Health Ab filed Critical Pfizer Health Ab
Publication of PT1023077E publication Critical patent/PT1023077E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Prostheses (AREA)
  • Dental Preparations (AREA)
  • Luminescent Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
PT98908415T 1997-03-07 1998-03-06 Composicao oftalmica PT1023077E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9700827A SE9700827D0 (sv) 1997-03-07 1997-03-07 Ophthalmic composition

Publications (1)

Publication Number Publication Date
PT1023077E true PT1023077E (pt) 2005-04-29

Family

ID=20406068

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98908415T PT1023077E (pt) 1997-03-07 1998-03-06 Composicao oftalmica

Country Status (14)

Country Link
US (1) US6086597A (pt)
EP (1) EP1023077B1 (pt)
JP (2) JP3481952B2 (pt)
AT (1) ATE288274T1 (pt)
AU (1) AU749522B2 (pt)
CA (1) CA2282757C (pt)
DE (1) DE69828894T2 (pt)
DK (1) DK1023077T3 (pt)
ES (1) ES2236890T3 (pt)
HK (1) HK1029929A1 (pt)
IL (1) IL131663A0 (pt)
PT (1) PT1023077E (pt)
SE (1) SE9700827D0 (pt)
WO (1) WO1998039015A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030018382A1 (en) * 2001-07-17 2003-01-23 Pflugfelder Stephen C. Process for improving vision
US20050064012A1 (en) * 2001-07-17 2005-03-24 Baylor College Of Medicine Process for causing myopic shift in vision
US7820194B2 (en) * 2001-12-21 2010-10-26 Alcon, Inc. Combinations of viscoelastics for use during surgery
US20040101561A1 (en) * 2002-11-13 2004-05-27 Jafari Masoud R. Combinations of viscoelastics for use during surgery
US20040167480A1 (en) * 2003-02-21 2004-08-26 Advanced Medical Optics, Inc. Administration of multiple viscoelastic solutions with a multi-compartment syringe
US20050250737A1 (en) * 2003-11-12 2005-11-10 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20050215516A1 (en) * 2004-03-29 2005-09-29 Claudio Bucolo New free-radical scavenger containing viscoelastic composition, methods of use and package
US8802651B2 (en) * 2004-06-30 2014-08-12 Abbott Medical Optics Inc. Hyaluronic acid in the enhancement of lens regeneration
US20060073184A1 (en) * 2004-09-29 2006-04-06 Bausch & Lomb Inc. Viscoelastic composition, methods of use and packaging device with anti-oxidant
WO2007030623A2 (en) * 2005-09-07 2007-03-15 Amo Regional Holdings Bi-modal hyaluronate solution
JP2007145765A (ja) * 2005-11-29 2007-06-14 Menicon Co Ltd 眼科手術用組成物
US7674781B2 (en) * 2006-04-28 2010-03-09 Heather Sheardown Hyaluronic acid-retaining polymers
US20130108550A1 (en) 2011-10-26 2013-05-02 Abbott Cardiovasculr Systems, Inc. Bioabsorbable Co-Filler for Cerebrovascular Aneurysms
JP6357228B2 (ja) 2013-07-10 2018-07-11 マトリックス バイオロジー インスティテュート 高い弾性を有するヒアルロナンの組成物およびその使用
WO2017053339A1 (en) 2015-09-24 2017-03-30 Matrix Biology Institute High elasticity hyaluronan compositions and methods of use thereof
KR20190068575A (ko) * 2016-10-14 2019-06-18 이콤 메디칼 게엠베하 안구 표면 항상성의 확립, 회복 및 보존 방법
JPWO2021220712A1 (pt) * 2020-04-30 2021-11-04

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112350A (en) * 1986-10-16 1992-05-12 Cbs Lens, A California General Partnership Method for locating on a cornea an artificial lens fabricated from a collagen-hydrogel for promoting epithelial cell growth and regeneration of the stroma
US4920104A (en) * 1988-05-16 1990-04-24 Medchem Products, Inc. Sodium hyaluronate composition
US4978352A (en) * 1989-06-07 1990-12-18 Fedorov Svjatoslav N Process for producing collagen-based cross-linked biopolymer, an implant from said biopolymer, method for producing said implant, and method for hermetization of corneal or scleral wounds involved in eye injuries, using said implant
EP0414373B2 (en) * 1989-07-24 2001-04-25 Allergan Pharmaceuticals (Ireland) Limited Stable solution of hyaluronate in a balanced salt medium
US5492936A (en) * 1990-11-30 1996-02-20 Allergan, Inc. Bimodal molecular weight hyaluronate formulations and methods for using same
US5273056A (en) * 1992-06-12 1993-12-28 Alcon Laboratories, Inc. Use of combinations of viscoelastics during surgery
WO1995013766A1 (en) * 1993-11-18 1995-05-26 Allergan, Inc. Deformable lens insertion apparatus
US5604244A (en) * 1995-06-07 1997-02-18 Alcon Laboratories, Inc. Intraocular irrigating solution containing a polyamine antagonist

Also Published As

Publication number Publication date
IL131663A0 (en) 2001-01-28
EP1023077A1 (en) 2000-08-02
JP2004131489A (ja) 2004-04-30
CA2282757A1 (en) 1998-09-11
ES2236890T3 (es) 2005-07-16
ATE288274T1 (de) 2005-02-15
SE9700827D0 (sv) 1997-03-07
AU6644898A (en) 1998-09-22
WO1998039015A1 (en) 1998-09-11
AU749522B2 (en) 2002-06-27
DK1023077T3 (da) 2005-05-30
EP1023077B1 (en) 2005-02-02
DE69828894T2 (de) 2006-01-19
HK1029929A1 (en) 2001-04-20
DE69828894D1 (de) 2005-03-10
JP3481952B2 (ja) 2003-12-22
JP2001515531A (ja) 2001-09-18
US6086597A (en) 2000-07-11
CA2282757C (en) 2003-06-03

Similar Documents

Publication Publication Date Title
ATE288274T1 (de) Ophatlmologische zusammenssetzung
BR9916358A (pt) Conjunto de composição para uso em cirurgia intra-ocular, e, kit para uso em cirurgia intra-ocular
EA199700286A1 (ru) Соединение для офтальмологической хирургии и способ ее осуществления
FR2878444B1 (fr) Solutions viscoelastiques renfermant du hyaluronate de sodiu et de l'hydroxypropylmethylcellulose, preparation et utilisations
TR200302105T4 (tr) Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları.
HUP0001818A2 (hu) A szem első kamrájában alkalmazható szabályzott felszabadulású gyógyszerhatóanyagok
ATE262859T1 (de) Multifokale phakische intraokularlinse
DE60323107D1 (de) Behandlungs methode und lösung zur hemmung der trübung der hinteren kapsel
WO1995016435A3 (en) Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
MXPA03005922A (es) Metodo para tratar glaucoma ib.
TR200002687T2 (tr) Glikojen içeren oftalmik çözelti
DE60000736D1 (de) Miotische wirkstoffe und hypertonische wirkstoffe enthaltende ophthalmische zusammensetzungen
US20010038860A1 (en) Ocular tissue regeneration inducer
DE69914066T2 (de) Augenspüllösung
PT1330246E (pt) Utilizacao de derivados do acido hidroxieicosatetraenoico em cirurgia intraocular
DE69614577D1 (de) Polyamin-antagonisten enthaltende intraokulare irrigationslösung
DK0453337T3 (da) Anvendelse af hexetidin eller derivater eller salte deraf til fremstilling af et farmaceutisk præparat til oftalmologisk anvendelse
MX9603974A (es) Aparato para sellar un recipiente.
IT236181Y1 (it) Punta perfezionata per chirurgia oculistica,in particolare per larimozione della cataratta
UA36465A (uk) Спосіб ушивання глибоких і нешироких ран та голка для його здійснення
RU93015155A (ru) Лекарственное средство для лечения дистрофических заболеваний и травм глазных тканей